7 assets in Stage IVb Bladder Cancer

Therapeutic assets addressing Stage IVb Bladder Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Nivolumab Stage IVb Bladder Cancer	M.D. Anderson Cancer Center	P2	B (63)
Pembrolizumab Stage IVb Bladder Cancer	M.D. Anderson Cancer Center	P1/2	B (57)
Relatlimab Stage IVb Bladder Cancer	M.D. Anderson Cancer Center	P2	CCC (53)
Carboplatin Stage IVb Bladder Cancer	Jonsson Comprehensive Cancer Center	P1	CC (43)
Cis-Diamminedichloroplatinum Ii Stage IVb Bladder Cancer	Jonsson Comprehensive Cancer Center	P1	CC (43)
Docetaxel Stage IVb Bladder Cancer	Jonsson Comprehensive Cancer Center	P1	CC (43)
Etoposide Stage IVb Bladder Cancer	Jonsson Comprehensive Cancer Center	P1	CC (43)